Medication info
Telmisartan 40 mg Tablets

Telmisartan 40 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
White or almost white, biconvex, round tablets
Packaging
30 tablets/box [(10 tablets/PTP) X 3]
Approval status
Active

MFDS item code 201607284 · Approved 2016.12.27 · Insurance code 645906160

Summary

Main use
Treatment of essential hypertension and prevention of cardiovascular disease
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan should be administered orally at a dose of 40 mg once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is observed 4 ∼ 8 weeks after starting treatment. This drug has an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive drugs may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and prevention of cardiovascular disease

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • high-risk diabetes with clinical evidence of end-organ damage
View approved original text

This medicine is used for the treatment of essential hypertension. Additionally, it helps reduce the risk of myocardial infarction, stroke, and cardiovascular disease-related mortality in patients aged 55 and older who are at high risk for cardiovascular diseases, particularly those with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attacks, evidence of end-organ damage, or high-risk diabetes. Therefore, this drug is used in the treatment of hypertension and prevention of cardiovascular diseases.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan should be administered orally at a dose of 40 mg once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is observed 4 ∼ 8 weeks after starting treatment. This drug has an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive drugs may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication may cause serious harm to the fetus and newborn, especially during pregnancy, and should be discontinued immediately if pregnancy is confirmed. Individuals with allergies to this drug or its ingredients, pregnant or breastfeeding women, those with severe liver dysfunction, history of hereditary angioedema, and those with diabetes or moderate to severe renal impairment should not use this medication. Elderly individuals, patients with hyperkalemia, those with liver dysfunction, cardiovascular diseases, gastrointestinal disorders, or renal vascular diseases should use this medication with caution. Various adverse reactions may occur during this treatment, including infections, blood abnormalities, allergic reactions, hypotension, liver dysfunction, and renal dysfunction, so the patient's condition should be closely monitored. If symptoms of angioedema, muscle pain, weakness, dizziness, or shock appear, medical personnel should be notified immediately. Patients with impaired renal function should have their serum potassium and creatinine levels checked regularly, as hypotension may occur if blood volume is decreased or salt is lacking. The blood-pressure-lowering effect of this medication may be enhanced when used with other antihypertensive drugs, so it is essential to consult healthcare providers regarding interactions with other medications being taken. Particularly, when used with ACE inhibitors, aliskiren, potassium-sparing diuretics, lithium, and non-steroidal anti-inflammatory drugs (NSAIDs), the risk of renal impairment, hyperkalemia, and hypotension may increase. Pregnant or potentially pregnant women should avoid taking this medication, and those who are breastfeeding are also advised to refrain from its use. Safety and efficacy have not been established for children under 18 years of age, so its use is not recommended. The elderly should use caution due to the risk of excessive blood pressure reduction leading to stroke or other complications. In case of overdose, severe hypotension, dizziness, and acute renal failure may occur, necessitating an immediate visit to a medical institution for appropriate treatment. This medication should be stored out of the reach of children, and the sealed packaging should not be opened until just before use. Care should be taken while driving or operating machinery, as fainting or dizziness may occur.

Side effects

  • Upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 114 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distention
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbance
  • hepatic dysfunction
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin eruption
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • hunger
  • cold sweat
  • hand tremors
  • decreased concentration
  • seizures
  • altered consciousness
  • angioedema
  • laryngeal edema
  • hyperkalemia
  • renal dysfunction
  • shock
  • loss of consciousness
  • hepatic dysfunction
  • jaundice
  • anaphylaxis-like symptoms
  • interstitial pneumonia
  • rhabdomyolysis
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • headache
  • dizziness
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • anorexia
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • anorexia
  • weakness
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea
  • hypotension
  • tachycardia
  • bradycardia
  • dizziness
  • acute renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture, preferably at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the drug's effectiveness and ensures safe use.

Appearance and packaging

Appearance

White or almost white, biconvex, round tablets

Package unit

30 tablets/box [(10 tablets/PTP) X 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.